CASE REPORT OF ADULT-ONSET CHARCOT MARIE TOOTH TYPE X
Keywords:Charcot-Marie-Tooth, adult onset, type X
AbstractCharcot-Marie-Tooth (CMT) or Hereditary Motor and Sensory Neuropathy (HMSN) is the most common hereditary peripheral nerve disease with progressive chronic weakness, muscle atrophy, and sensory disturbances. There are several types and subtypes of CMT with their respective clinical manifestations. In this article, we reported a patient with of CMT type X. A 43-year-old male patient was referred to a neurology clinic with weakness in both limbs for 2 years, accompanied by tingling and sensory disturbance in both hands and feet. There are several of his family members who had similar complaints. Lumbosacral magnetic resonance imaging (MRI) examination revealed mild nucleus pulposus herniation. Electroneuromyography (ENMG) examination revealed demyelinating sensory motor polyneuropathy. Histopathological examination of nerve biopsy showed demyelination of the sural nerve. It is hard to make a diagnosis of CMT, because it requires high suspicion from clinicians once encounter a suspected case and also need to supported by sophisticated equipment such as electrophysiological examinations, nerve biopsy examinations, and genetic examinations. It is vital for clinicians for being able to diagnose CMT correctly and provide treatment as soon as possible in order to maintain the patientsâ€™ quality of life.
Timothy CP. Charcot-Marie-Tooth and other hereditary motor and sensory neuropathies; 2018. [Cited 2021 Mar 10]. Available from: https://emedicine.medscape.com/article/1173104-overview
Thomas DB. Charcot-Marie-Tooth (CMT) hereditary neuropathy overview; 2021. [Cited 2021 Mar 10]. Available from:
Lokesh RM, Raju K, and Nagarathna PKM. A detailed study on a rare disease: Charcot Marie Tooth (CMT). Journal of Pharmacy and Biological Sciences; 2014; 9(2): 29-39.
National Institute of Neurological Disorders and Stroke. Charcot-Marie-Tooth disease fact sheet. [Updated 2020; Cited 2021 Mar 10]. Available from: https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Charcot-Marie-Tooth-Disease-Fact-Sheet#3092_3
Dimitrios K, et al. Evidence for cognitive deficits in x-linked Charcot-Marie-Tooth disease. Journal of the International Neurophysiological Society; 2020: 1-9. DOI: https://doi.org/10.1017/S1355617719001188
Donald MC, Evan MP, and Nicholas EJ. Management of Charcot-Marie-Tooth disease: Improving long-term care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare; 2016; 9: 7-19.
Laurie G and Michael S. Update on Charcot-Marie-Tooth disease. Current Opinion Neurology; 2015; 28 (5): 462-7. DOI: 10.1097/WCO.0000000000000237
Lidiane CLSB, et al. Epidemiologic study of Charcot-Marie-Tooth disease: A systematic review. Neuroepidemiology; 2016; 46: 157-65.
Kenny M, Jimmy S, Octaviani. Advanced onset Marie Tooth Charcot Disease. Neurona; 2020; 31 (2): 1-7. Avalaible from:
Carlo F, et al. Charcot-Marie-Toot disease with pyramidal features due to a mutation of EGR2 gene. Acta Biomedica Journal; 2019; 90 (1): 104-6.
Berciano J, et al. Intermediate Charcot-Marie-Tooth disease: An electrophysiological reappraisal and systematic review. Journal of Neurology; 2017: 1-25. DOI: 10.1007/s00415-017-8474-3
Jonathan M, Anirudh G, and Hoyle JC. Charcot-Marie-Tooth: From molecules to therapy. International Journal of Molecular Sciences; 2019; 20: 1-15. DOI: 10.3390/ijms20143419
Kumar V, et al. Robbins & Cotran pathologic basis of disease-8th ed. Philadelphia: Saunders Elsevier. 2010. ISBN: 9781416031215
This work is licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License